130 related articles for article (PubMed ID: 32012456)
1. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry.
Wu HY; Pan YY; Kopylov AT; Zgoda V; Ma MC; Wang CH; Su WC; Lai WW; Cheng PN; Liao PC
Proteomics Clin Appl; 2020 Jul; 14(4):e1900095. PubMed ID: 32012456
[TBL] [Abstract][Full Text] [Related]
2. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
3. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
[TBL] [Abstract][Full Text] [Related]
4. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.
Park J; Yang JS; Jung G; Woo HI; Park HD; Kim JW; Huh W; Ko JW; Kim H; Cho JY; Lee SY
J Proteomics; 2013 Dec; 94():302-10. PubMed ID: 24120528
[TBL] [Abstract][Full Text] [Related]
5. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
6. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.
Zhou M; Kong Y; Wang X; Li W; Chen S; Wang L; Wang C; Zhang Q
Biomed Res Int; 2021; 2021():5561569. PubMed ID: 33728331
[TBL] [Abstract][Full Text] [Related]
8. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
10. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
12. Method and platform standardization in MRM-based quantitative plasma proteomics.
Percy AJ; Chambers AG; Yang J; Jackson AM; Domanski D; Burkhart J; Sickmann A; Borchers CH
J Proteomics; 2013 Dec; 95():66-76. PubMed ID: 23933160
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.
Lee HB; Kang UB; Moon HG; Lee J; Lee KM; Yi M; Park YS; Lee JW; Yu JH; Choi SH; Cho SH; Lee C; Han W; Noh DY
Anticancer Res; 2015 Nov; 35(11):6271-9. PubMed ID: 26504062
[TBL] [Abstract][Full Text] [Related]
14. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
Turtoi A; Mazzucchelli GD; De Pauw E
Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.
Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL
J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982
[TBL] [Abstract][Full Text] [Related]
16. Increased Depth and Breadth of Plasma Protein Quantitation via Two-Dimensional Liquid Chromatography/Multiple Reaction Monitoring-Mass Spectrometry with Labeled Peptide Standards.
Percy AJ; Yang J; Chambers AG; Borchers CH
Methods Mol Biol; 2016; 1410():1-21. PubMed ID: 26867735
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.
Percy AJ; Simon R; Chambers AG; Borchers CH
J Proteomics; 2014 Jun; 106():113-24. PubMed ID: 24769237
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Lee SM; Upadhyay S; Lewanski C; Falk S; Skailes G; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Rudd R; Ngai Y; Edwards A; Hackshaw A
Eur J Cancer; 2019 Oct; 120():86-96. PubMed ID: 31499384
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
Shin J; Song SY; Ahn HS; An BC; Choi YD; Yang EG; Na KJ; Lee ST; Park JI; Kim SY; Lee C; Lee SW
PLoS One; 2017; 12(8):e0183896. PubMed ID: 28837649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
